Atlas Trials

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

Clinical trial NCT01494857 · UNKNOWN

Trial details

NCT number
NCT01494857
Sponsor
Clalit Health Services
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2012-01-01
Primary completion
2013-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.